In the RF prediction model based on the Ph-like ALL data of our collaborative group, IK6 deletion and molecular genetic changes involving kinase pathways, such as CRLF2 rearrangement or overexpression, JAK mutations, or JAK fusion proteins, have no significant impact on the prognosis of Ph-like ALL. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.